Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

3 days Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

PFE ends deal with SGMO for hemophilia A gene therapy candidate. NVS’ gene therapy for SMA meets goal in study.

Pfizer (PFE)

  X     

2 days Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

   X     

3 days Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

   X     

3 days Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

   X     

3 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

3 days The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

   X     

3 days Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

   X     

3 days Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

   X     

4 days Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

   X     

4 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

5 days Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

   X     

6 days 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

   X     

6 days Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

   X     

6 days Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

   X     

6 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

6 days Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

   X     

6 days Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

   X     

6 days Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

   X     

6 days NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

   X     

6 days 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

   X     

6 days Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

   X     

6 days SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

   X     

6 days Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

   X     

7 days Pfizer: One Of The Next Big AI Winners Seeking Alpha

   X     

1 week Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

   X     

2 weeks Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

   X     

2 weeks Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

   X     

2 weeks Better Income Stock: Pfizer or Altria Group? Yahoo Finance

   X     

2 weeks Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

   X     

2 weeks Should Value Investors Buy Pfizer (PFE) Stock? Zacks

   X     

2 weeks Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 weeks Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

   X     

2 weeks Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

   X     

2 weeks Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

   X     

2 weeks Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks

   X     

3 weeks Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha

   X     

3 weeks Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha

   X     

3 weeks Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks

   X     

3 weeks Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily

   X     

3 weeks Final Trade: GOOG, SAIA, X, PFE YouTube

   X     

3 weeks Pfizer climbs 4% on 2025 outlook YouTube

   X     

3 weeks Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

   X     

3 weeks Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

   X     

3 weeks Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

   X     

3 weeks Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

   X     

3 weeks Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

   X     

3 weeks Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

   X     

3 weeks Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

   X     

3 weeks Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

   X     

3 weeks AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

   X     

3 weeks Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News